Skip to main content
. Author manuscript; available in PMC: 2008 Oct 20.
Published in final edited form as: Vascul Pharmacol. 2007 Feb 2;46(6):439–448. doi: 10.1016/j.vph.2007.01.005

Figure 7.

Figure 7

Western Blot of HPAEC 72 hr treatment; DMF vehicle (C1–C3) vs. 60 μg/ml MCTP (M1–M3): A) Expression of BMPrII is significantly decreased in MCTP treated cells (p= 0.05). No significant change was present in treated cells for B) Alk1 (p= 0.07) or C) Smad 4. D) Smad 6 expression is significantly increased (p= 0.035) while E) Phospho-p38 MAPK is significantly decreased (p= 0.012). No change was evident in F) ID 1 (p= 0.51) or G) Cav-1 (p= 0.58). All lanes contain 50 μg protein. G) Densitometric analysis of 72 hr. western blots (* p<.05).